INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY) announced today that Anat Ashkenazi has resigned from her position as Chief Financial Officer (CFO) to explore a new career... ByInvesting.com ...

Alphabet (NASDAQ:GOOGL) has appointed Anat Ashkenazi as its new chief financial officer (CFO), bringing on board a seasoned executive with two decades of experience at Eli Lilly... ByInvesting.com ...

One of the highlights of Eli Lilly's third-quarter results ... with fewer than 10% switching from Trulicity, said Lilly's chief financial officer Anat Ashkenazi on the call. Now, Lilly's focus ...

Meanwhile, CFO Anat Ashkenazi is also betting on the technology ... from an impressive career as finance chief at drugmaker Eli Lilly. On her debut earnings call in Q3 last October, she stated ...

Meanwhile, CFO Anat Ashkenazi is also betting on the technology to boost ... joining the tech giant from an impressive career as finance chief at drugmaker Eli Lilly. On her debut earnings call in Q3 ...

The new CFO, Anat Ashkenazi, you might remember, she was at Eli Lilly, she tells a terrific story. We’ll be listening for anything about the growth of Google’s cloud infrastructure business.

For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...

Eli Lilly expands its partnership with AdvanCell to advance targeted alpha therapies using Pb-212 technology for cancer treatment. Lilly inks a global licensing deal with OliX for OLX75016 ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

On Monday, Eli Lilly And Co (NYSE:LLY) inked two strategic collaborations to expand radiopharmaceuticals and metabolic-associated steatohepatitis (MASH), respectively. AdvanCell announced that it ...